ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Chronic Hepatitis B Treatment Oral Drugs Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-13N17276
Home | Market Reports | Health| Pharmacy
Global Chronic Hepatitis B Treatment Oral Drugs Market Research Report 2024
BUY CHAPTERS

Global Chronic Hepatitis B Treatment Oral Drugs Market Research Report 2024

Code: QYRE-Auto-13N17276
Report
May 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Companies
Gilead Sciences
Bristol–Myers Squibb
GSK
Novartis
Roche
Merck
Johnson & Johnson
Dawnrays Pharmaceutical
Hansoh Pharmaceutical
Chia Tai-Tianqing Pharmaceutical
Qilu Pharmaceutical
Fujian Cosunter Pharma
Xiamen Amoytop Biotech
YaoPharma
Kelun Pharmaceutical

Chronic Hepatitis B Treatment Oral Drugs Market

The global Chronic Hepatitis B Treatment Oral Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Chronic Hepatitis B Treatment Oral Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chronic Hepatitis B Treatment Oral Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Chronic Hepatitis B Treatment Oral Drugs in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Chronic Hepatitis B Treatment Oral Drugs include GSK, Bristol Myers Squibb, Gilead Sciences, Novartis, Roche, Merck, Johnson & Johnson, Dawnrays Pharmaceutical, Hansoh Pharmaceutical, Chia Tai-Tianqing Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Chronic Hepatitis B Treatment Oral Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Hepatitis B Treatment Oral Drugs.
The Chronic Hepatitis B Treatment Oral Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Hepatitis B Treatment Oral Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Hepatitis B Treatment Oral Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Chronic Hepatitis B Treatment Oral Drugs Market Report

Report Metric Details
Report Name Chronic Hepatitis B Treatment Oral Drugs Market
Segment by Type
  • Entecavir
  • Tenofovir
  • Lamivudine
  • Adefovir
  • Telbivudine
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GSK, Bristol Myers Squibb, Gilead Sciences, Novartis, Roche, Merck, Johnson & Johnson, Dawnrays Pharmaceutical, Hansoh Pharmaceutical, Chia Tai-Tianqing Pharmaceutical, Qilu pharmaceutical, Fujian Cosunter Pharma, Xiamen Amoytop Biotech, YaoPharma, Kelun Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Chronic Hepatitis B Treatment Oral Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Chronic Hepatitis B Treatment Oral Drugs Market report?

Ans: The main players in the Chronic Hepatitis B Treatment Oral Drugs Market are GSK, Bristol Myers Squibb, Gilead Sciences, Novartis, Roche, Merck, Johnson & Johnson, Dawnrays Pharmaceutical, Hansoh Pharmaceutical, Chia Tai-Tianqing Pharmaceutical, Qilu pharmaceutical, Fujian Cosunter Pharma, Xiamen Amoytop Biotech, YaoPharma, Kelun Pharmaceutical

What are the Application segmentation covered in the Chronic Hepatitis B Treatment Oral Drugs Market report?

Ans: The Applications covered in the Chronic Hepatitis B Treatment Oral Drugs Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Chronic Hepatitis B Treatment Oral Drugs Market report?

Ans: The Types covered in the Chronic Hepatitis B Treatment Oral Drugs Market report are Entecavir, Tenofovir, Lamivudine, Adefovir, Telbivudine, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Hepatitis B Treatment Oral Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Entecavir
1.2.3 Tenofovir
1.2.4 Lamivudine
1.2.5 Adefovir
1.2.6 Telbivudine
1.2.7 Others
1.3 Market by Application
1.3.1 Global Chronic Hepatitis B Treatment Oral Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Hepatitis B Treatment Oral Drugs Market Perspective (2019-2030)
2.2 Global Chronic Hepatitis B Treatment Oral Drugs Growth Trends by Region
2.2.1 Global Chronic Hepatitis B Treatment Oral Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Chronic Hepatitis B Treatment Oral Drugs Historic Market Size by Region (2019-2024)
2.2.3 Chronic Hepatitis B Treatment Oral Drugs Forecasted Market Size by Region (2025-2030)
2.3 Chronic Hepatitis B Treatment Oral Drugs Market Dynamics
2.3.1 Chronic Hepatitis B Treatment Oral Drugs Industry Trends
2.3.2 Chronic Hepatitis B Treatment Oral Drugs Market Drivers
2.3.3 Chronic Hepatitis B Treatment Oral Drugs Market Challenges
2.3.4 Chronic Hepatitis B Treatment Oral Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Hepatitis B Treatment Oral Drugs Players by Revenue
3.1.1 Global Top Chronic Hepatitis B Treatment Oral Drugs Players by Revenue (2019-2024)
3.1.2 Global Chronic Hepatitis B Treatment Oral Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Chronic Hepatitis B Treatment Oral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Chronic Hepatitis B Treatment Oral Drugs Revenue
3.4 Global Chronic Hepatitis B Treatment Oral Drugs Market Concentration Ratio
3.4.1 Global Chronic Hepatitis B Treatment Oral Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Hepatitis B Treatment Oral Drugs Revenue in 2023
3.5 Global Key Players of Chronic Hepatitis B Treatment Oral Drugs Head office and Area Served
3.6 Global Key Players of Chronic Hepatitis B Treatment Oral Drugs, Product and Application
3.7 Global Key Players of Chronic Hepatitis B Treatment Oral Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Hepatitis B Treatment Oral Drugs Breakdown Data by Type
4.1 Global Chronic Hepatitis B Treatment Oral Drugs Historic Market Size by Type (2019-2024)
4.2 Global Chronic Hepatitis B Treatment Oral Drugs Forecasted Market Size by Type (2025-2030)
5 Chronic Hepatitis B Treatment Oral Drugs Breakdown Data by Application
5.1 Global Chronic Hepatitis B Treatment Oral Drugs Historic Market Size by Application (2019-2024)
5.2 Global Chronic Hepatitis B Treatment Oral Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Chronic Hepatitis B Treatment Oral Drugs Market Size (2019-2030)
6.2 North America Chronic Hepatitis B Treatment Oral Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Chronic Hepatitis B Treatment Oral Drugs Market Size by Country (2019-2024)
6.4 North America Chronic Hepatitis B Treatment Oral Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Hepatitis B Treatment Oral Drugs Market Size (2019-2030)
7.2 Europe Chronic Hepatitis B Treatment Oral Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Chronic Hepatitis B Treatment Oral Drugs Market Size by Country (2019-2024)
7.4 Europe Chronic Hepatitis B Treatment Oral Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Hepatitis B Treatment Oral Drugs Market Size (2019-2030)
8.2 Asia-Pacific Chronic Hepatitis B Treatment Oral Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Chronic Hepatitis B Treatment Oral Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Chronic Hepatitis B Treatment Oral Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Hepatitis B Treatment Oral Drugs Market Size (2019-2030)
9.2 Latin America Chronic Hepatitis B Treatment Oral Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Chronic Hepatitis B Treatment Oral Drugs Market Size by Country (2019-2024)
9.4 Latin America Chronic Hepatitis B Treatment Oral Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Hepatitis B Treatment Oral Drugs Market Size (2019-2030)
10.2 Middle East & Africa Chronic Hepatitis B Treatment Oral Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Chronic Hepatitis B Treatment Oral Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Chronic Hepatitis B Treatment Oral Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Chronic Hepatitis B Treatment Oral Drugs Introduction
11.1.4 GSK Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
11.1.5 GSK Recent Development
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Details
11.2.2 Bristol Myers Squibb Business Overview
11.2.3 Bristol Myers Squibb Chronic Hepatitis B Treatment Oral Drugs Introduction
11.2.4 Bristol Myers Squibb Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
11.2.5 Bristol Myers Squibb Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Chronic Hepatitis B Treatment Oral Drugs Introduction
11.3.4 Gilead Sciences Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
11.3.5 Gilead Sciences Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Chronic Hepatitis B Treatment Oral Drugs Introduction
11.4.4 Novartis Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Chronic Hepatitis B Treatment Oral Drugs Introduction
11.5.4 Roche Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
11.5.5 Roche Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Chronic Hepatitis B Treatment Oral Drugs Introduction
11.6.4 Merck Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
11.6.5 Merck Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Chronic Hepatitis B Treatment Oral Drugs Introduction
11.7.4 Johnson & Johnson Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
11.7.5 Johnson & Johnson Recent Development
11.8 Dawnrays Pharmaceutical
11.8.1 Dawnrays Pharmaceutical Company Details
11.8.2 Dawnrays Pharmaceutical Business Overview
11.8.3 Dawnrays Pharmaceutical Chronic Hepatitis B Treatment Oral Drugs Introduction
11.8.4 Dawnrays Pharmaceutical Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
11.8.5 Dawnrays Pharmaceutical Recent Development
11.9 Hansoh Pharmaceutical
11.9.1 Hansoh Pharmaceutical Company Details
11.9.2 Hansoh Pharmaceutical Business Overview
11.9.3 Hansoh Pharmaceutical Chronic Hepatitis B Treatment Oral Drugs Introduction
11.9.4 Hansoh Pharmaceutical Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
11.9.5 Hansoh Pharmaceutical Recent Development
11.10 Chia Tai-Tianqing Pharmaceutical
11.10.1 Chia Tai-Tianqing Pharmaceutical Company Details
11.10.2 Chia Tai-Tianqing Pharmaceutical Business Overview
11.10.3 Chia Tai-Tianqing Pharmaceutical Chronic Hepatitis B Treatment Oral Drugs Introduction
11.10.4 Chia Tai-Tianqing Pharmaceutical Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
11.10.5 Chia Tai-Tianqing Pharmaceutical Recent Development
11.11 Qilu pharmaceutical
11.11.1 Qilu pharmaceutical Company Details
11.11.2 Qilu pharmaceutical Business Overview
11.11.3 Qilu pharmaceutical Chronic Hepatitis B Treatment Oral Drugs Introduction
11.11.4 Qilu pharmaceutical Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
11.11.5 Qilu pharmaceutical Recent Development
11.12 Fujian Cosunter Pharma
11.12.1 Fujian Cosunter Pharma Company Details
11.12.2 Fujian Cosunter Pharma Business Overview
11.12.3 Fujian Cosunter Pharma Chronic Hepatitis B Treatment Oral Drugs Introduction
11.12.4 Fujian Cosunter Pharma Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
11.12.5 Fujian Cosunter Pharma Recent Development
11.13 Xiamen Amoytop Biotech
11.13.1 Xiamen Amoytop Biotech Company Details
11.13.2 Xiamen Amoytop Biotech Business Overview
11.13.3 Xiamen Amoytop Biotech Chronic Hepatitis B Treatment Oral Drugs Introduction
11.13.4 Xiamen Amoytop Biotech Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
11.13.5 Xiamen Amoytop Biotech Recent Development
11.14 YaoPharma
11.14.1 YaoPharma Company Details
11.14.2 YaoPharma Business Overview
11.14.3 YaoPharma Chronic Hepatitis B Treatment Oral Drugs Introduction
11.14.4 YaoPharma Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
11.14.5 YaoPharma Recent Development
11.15 Kelun Pharmaceutical
11.15.1 Kelun Pharmaceutical Company Details
11.15.2 Kelun Pharmaceutical Business Overview
11.15.3 Kelun Pharmaceutical Chronic Hepatitis B Treatment Oral Drugs Introduction
11.15.4 Kelun Pharmaceutical Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
11.15.5 Kelun Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Companies
Gilead Sciences
Bristol–Myers Squibb
GSK
Novartis
Roche
Merck
Johnson & Johnson
Dawnrays Pharmaceutical
Hansoh Pharmaceutical
Chia Tai-Tianqing Pharmaceutical
Qilu Pharmaceutical
Fujian Cosunter Pharma
Xiamen Amoytop Biotech
YaoPharma
Kelun Pharmaceutical
List of Tables
 Table 1. Global Chronic Hepatitis B Treatment Oral Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Entecavir
 Table 3. Key Players of Tenofovir
 Table 4. Key Players of Lamivudine
 Table 5. Key Players of Adefovir
 Table 6. Key Players of Telbivudine
 Table 7. Key Players of Others
 Table 8. Global Chronic Hepatitis B Treatment Oral Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 9. Global Chronic Hepatitis B Treatment Oral Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 10. Global Chronic Hepatitis B Treatment Oral Drugs Market Size by Region (2019-2024) & (US$ Million)
 Table 11. Global Chronic Hepatitis B Treatment Oral Drugs Market Share by Region (2019-2024)
 Table 12. Global Chronic Hepatitis B Treatment Oral Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 13. Global Chronic Hepatitis B Treatment Oral Drugs Market Share by Region (2025-2030)
 Table 14. Chronic Hepatitis B Treatment Oral Drugs Market Trends
 Table 15. Chronic Hepatitis B Treatment Oral Drugs Market Drivers
 Table 16. Chronic Hepatitis B Treatment Oral Drugs Market Challenges
 Table 17. Chronic Hepatitis B Treatment Oral Drugs Market Restraints
 Table 18. Global Chronic Hepatitis B Treatment Oral Drugs Revenue by Players (2019-2024) & (US$ Million)
 Table 19. Global Chronic Hepatitis B Treatment Oral Drugs Market Share by Players (2019-2024)
 Table 20. Global Top Chronic Hepatitis B Treatment Oral Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Hepatitis B Treatment Oral Drugs as of 2023)
 Table 21. Ranking of Global Top Chronic Hepatitis B Treatment Oral Drugs Companies by Revenue (US$ Million) in 2023
 Table 22. Global 5 Largest Players Market Share by Chronic Hepatitis B Treatment Oral Drugs Revenue (CR5 and HHI) & (2019-2024)
 Table 23. Global Key Players of Chronic Hepatitis B Treatment Oral Drugs, Headquarters and Area Served
 Table 24. Global Key Players of Chronic Hepatitis B Treatment Oral Drugs, Product and Application
 Table 25. Global Key Players of Chronic Hepatitis B Treatment Oral Drugs, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Chronic Hepatitis B Treatment Oral Drugs Market Size by Type (2019-2024) & (US$ Million)
 Table 28. Global Chronic Hepatitis B Treatment Oral Drugs Revenue Market Share by Type (2019-2024)
 Table 29. Global Chronic Hepatitis B Treatment Oral Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 30. Global Chronic Hepatitis B Treatment Oral Drugs Revenue Market Share by Type (2025-2030)
 Table 31. Global Chronic Hepatitis B Treatment Oral Drugs Market Size by Application (2019-2024) & (US$ Million)
 Table 32. Global Chronic Hepatitis B Treatment Oral Drugs Revenue Market Share by Application (2019-2024)
 Table 33. Global Chronic Hepatitis B Treatment Oral Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 34. Global Chronic Hepatitis B Treatment Oral Drugs Revenue Market Share by Application (2025-2030)
 Table 35. North America Chronic Hepatitis B Treatment Oral Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. North America Chronic Hepatitis B Treatment Oral Drugs Market Size by Country (2019-2024) & (US$ Million)
 Table 37. North America Chronic Hepatitis B Treatment Oral Drugs Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Europe Chronic Hepatitis B Treatment Oral Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 39. Europe Chronic Hepatitis B Treatment Oral Drugs Market Size by Country (2019-2024) & (US$ Million)
 Table 40. Europe Chronic Hepatitis B Treatment Oral Drugs Market Size by Country (2025-2030) & (US$ Million)
 Table 41. Asia-Pacific Chronic Hepatitis B Treatment Oral Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 42. Asia-Pacific Chronic Hepatitis B Treatment Oral Drugs Market Size by Region (2019-2024) & (US$ Million)
 Table 43. Asia-Pacific Chronic Hepatitis B Treatment Oral Drugs Market Size by Region (2025-2030) & (US$ Million)
 Table 44. Latin America Chronic Hepatitis B Treatment Oral Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Latin America Chronic Hepatitis B Treatment Oral Drugs Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Latin America Chronic Hepatitis B Treatment Oral Drugs Market Size by Country (2025-2030) & (US$ Million)
 Table 47. Middle East & Africa Chronic Hepatitis B Treatment Oral Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 48. Middle East & Africa Chronic Hepatitis B Treatment Oral Drugs Market Size by Country (2019-2024) & (US$ Million)
 Table 49. Middle East & Africa Chronic Hepatitis B Treatment Oral Drugs Market Size by Country (2025-2030) & (US$ Million)
 Table 50. GSK Company Details
 Table 51. GSK Business Overview
 Table 52. GSK Chronic Hepatitis B Treatment Oral Drugs Product
 Table 53. GSK Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024) & (US$ Million)
 Table 54. GSK Recent Development
 Table 55. Bristol Myers Squibb Company Details
 Table 56. Bristol Myers Squibb Business Overview
 Table 57. Bristol Myers Squibb Chronic Hepatitis B Treatment Oral Drugs Product
 Table 58. Bristol Myers Squibb Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024) & (US$ Million)
 Table 59. Bristol Myers Squibb Recent Development
 Table 60. Gilead Sciences Company Details
 Table 61. Gilead Sciences Business Overview
 Table 62. Gilead Sciences Chronic Hepatitis B Treatment Oral Drugs Product
 Table 63. Gilead Sciences Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024) & (US$ Million)
 Table 64. Gilead Sciences Recent Development
 Table 65. Novartis Company Details
 Table 66. Novartis Business Overview
 Table 67. Novartis Chronic Hepatitis B Treatment Oral Drugs Product
 Table 68. Novartis Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024) & (US$ Million)
 Table 69. Novartis Recent Development
 Table 70. Roche Company Details
 Table 71. Roche Business Overview
 Table 72. Roche Chronic Hepatitis B Treatment Oral Drugs Product
 Table 73. Roche Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024) & (US$ Million)
 Table 74. Roche Recent Development
 Table 75. Merck Company Details
 Table 76. Merck Business Overview
 Table 77. Merck Chronic Hepatitis B Treatment Oral Drugs Product
 Table 78. Merck Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024) & (US$ Million)
 Table 79. Merck Recent Development
 Table 80. Johnson & Johnson Company Details
 Table 81. Johnson & Johnson Business Overview
 Table 82. Johnson & Johnson Chronic Hepatitis B Treatment Oral Drugs Product
 Table 83. Johnson & Johnson Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024) & (US$ Million)
 Table 84. Johnson & Johnson Recent Development
 Table 85. Dawnrays Pharmaceutical Company Details
 Table 86. Dawnrays Pharmaceutical Business Overview
 Table 87. Dawnrays Pharmaceutical Chronic Hepatitis B Treatment Oral Drugs Product
 Table 88. Dawnrays Pharmaceutical Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024) & (US$ Million)
 Table 89. Dawnrays Pharmaceutical Recent Development
 Table 90. Hansoh Pharmaceutical Company Details
 Table 91. Hansoh Pharmaceutical Business Overview
 Table 92. Hansoh Pharmaceutical Chronic Hepatitis B Treatment Oral Drugs Product
 Table 93. Hansoh Pharmaceutical Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024) & (US$ Million)
 Table 94. Hansoh Pharmaceutical Recent Development
 Table 95. Chia Tai-Tianqing Pharmaceutical Company Details
 Table 96. Chia Tai-Tianqing Pharmaceutical Business Overview
 Table 97. Chia Tai-Tianqing Pharmaceutical Chronic Hepatitis B Treatment Oral Drugs Product
 Table 98. Chia Tai-Tianqing Pharmaceutical Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024) & (US$ Million)
 Table 99. Chia Tai-Tianqing Pharmaceutical Recent Development
 Table 100. Qilu pharmaceutical Company Details
 Table 101. Qilu pharmaceutical Business Overview
 Table 102. Qilu pharmaceutical Chronic Hepatitis B Treatment Oral Drugs Product
 Table 103. Qilu pharmaceutical Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024) & (US$ Million)
 Table 104. Qilu pharmaceutical Recent Development
 Table 105. Fujian Cosunter Pharma Company Details
 Table 106. Fujian Cosunter Pharma Business Overview
 Table 107. Fujian Cosunter Pharma Chronic Hepatitis B Treatment Oral Drugs Product
 Table 108. Fujian Cosunter Pharma Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024) & (US$ Million)
 Table 109. Fujian Cosunter Pharma Recent Development
 Table 110. Xiamen Amoytop Biotech Company Details
 Table 111. Xiamen Amoytop Biotech Business Overview
 Table 112. Xiamen Amoytop Biotech Chronic Hepatitis B Treatment Oral Drugs Product
 Table 113. Xiamen Amoytop Biotech Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024) & (US$ Million)
 Table 114. Xiamen Amoytop Biotech Recent Development
 Table 115. YaoPharma Company Details
 Table 116. YaoPharma Business Overview
 Table 117. YaoPharma Chronic Hepatitis B Treatment Oral Drugs Product
 Table 118. YaoPharma Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024) & (US$ Million)
 Table 119. YaoPharma Recent Development
 Table 120. Kelun Pharmaceutical Company Details
 Table 121. Kelun Pharmaceutical Business Overview
 Table 122. Kelun Pharmaceutical Chronic Hepatitis B Treatment Oral Drugs Product
 Table 123. Kelun Pharmaceutical Revenue in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024) & (US$ Million)
 Table 124. Kelun Pharmaceutical Recent Development
 Table 125. Research Programs/Design for This Report
 Table 126. Key Data Information from Secondary Sources
 Table 127. Key Data Information from Primary Sources
 Table 128. Authors List of This Report


List of Figures
 Figure 1. Chronic Hepatitis B Treatment Oral Drugs Picture
 Figure 2. Global Chronic Hepatitis B Treatment Oral Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Chronic Hepatitis B Treatment Oral Drugs Market Share by Type: 2023 VS 2030
 Figure 4. Entecavir Features
 Figure 5. Tenofovir Features
 Figure 6. Lamivudine Features
 Figure 7. Adefovir Features
 Figure 8. Telbivudine Features
 Figure 9. Others Features
 Figure 10. Global Chronic Hepatitis B Treatment Oral Drugs Market Size by Application (2024-2030) & (US$ Million)
 Figure 11. Global Chronic Hepatitis B Treatment Oral Drugs Market Share by Application: 2023 VS 2030
 Figure 12. Hospital Case Studies
 Figure 13. Clinic Case Studies
 Figure 14. Others Case Studies
 Figure 15. Chronic Hepatitis B Treatment Oral Drugs Report Years Considered
 Figure 16. Global Chronic Hepatitis B Treatment Oral Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 17. Global Chronic Hepatitis B Treatment Oral Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 18. Global Chronic Hepatitis B Treatment Oral Drugs Market Share by Region: 2023 VS 2030
 Figure 19. Global Chronic Hepatitis B Treatment Oral Drugs Market Share by Players in 2023
 Figure 20. Global Top Chronic Hepatitis B Treatment Oral Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Hepatitis B Treatment Oral Drugs as of 2023)
 Figure 21. The Top 10 and 5 Players Market Share by Chronic Hepatitis B Treatment Oral Drugs Revenue in 2023
 Figure 22. North America Chronic Hepatitis B Treatment Oral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. North America Chronic Hepatitis B Treatment Oral Drugs Market Share by Country (2019-2030)
 Figure 24. United States Chronic Hepatitis B Treatment Oral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Canada Chronic Hepatitis B Treatment Oral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. Europe Chronic Hepatitis B Treatment Oral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. Europe Chronic Hepatitis B Treatment Oral Drugs Market Share by Country (2019-2030)
 Figure 28. Germany Chronic Hepatitis B Treatment Oral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. France Chronic Hepatitis B Treatment Oral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. U.K. Chronic Hepatitis B Treatment Oral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Italy Chronic Hepatitis B Treatment Oral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Russia Chronic Hepatitis B Treatment Oral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Nordic Countries Chronic Hepatitis B Treatment Oral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Asia-Pacific Chronic Hepatitis B Treatment Oral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Asia-Pacific Chronic Hepatitis B Treatment Oral Drugs Market Share by Region (2019-2030)
 Figure 36. China Chronic Hepatitis B Treatment Oral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Japan Chronic Hepatitis B Treatment Oral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. South Korea Chronic Hepatitis B Treatment Oral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Southeast Asia Chronic Hepatitis B Treatment Oral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. India Chronic Hepatitis B Treatment Oral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Australia Chronic Hepatitis B Treatment Oral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Latin America Chronic Hepatitis B Treatment Oral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Latin America Chronic Hepatitis B Treatment Oral Drugs Market Share by Country (2019-2030)
 Figure 44. Mexico Chronic Hepatitis B Treatment Oral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Brazil Chronic Hepatitis B Treatment Oral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Middle East & Africa Chronic Hepatitis B Treatment Oral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Middle East & Africa Chronic Hepatitis B Treatment Oral Drugs Market Share by Country (2019-2030)
 Figure 48. Turkey Chronic Hepatitis B Treatment Oral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Chronic Hepatitis B Treatment Oral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 50. UAE Chronic Hepatitis B Treatment Oral Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 51. GSK Revenue Growth Rate in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
 Figure 52. Bristol Myers Squibb Revenue Growth Rate in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
 Figure 53. Gilead Sciences Revenue Growth Rate in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
 Figure 54. Novartis Revenue Growth Rate in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
 Figure 55. Roche Revenue Growth Rate in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
 Figure 56. Merck Revenue Growth Rate in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
 Figure 57. Johnson & Johnson Revenue Growth Rate in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
 Figure 58. Dawnrays Pharmaceutical Revenue Growth Rate in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
 Figure 59. Hansoh Pharmaceutical Revenue Growth Rate in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
 Figure 60. Chia Tai-Tianqing Pharmaceutical Revenue Growth Rate in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
 Figure 61. Qilu pharmaceutical Revenue Growth Rate in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
 Figure 62. Fujian Cosunter Pharma Revenue Growth Rate in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
 Figure 63. Xiamen Amoytop Biotech Revenue Growth Rate in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
 Figure 64. YaoPharma Revenue Growth Rate in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
 Figure 65. Kelun Pharmaceutical Revenue Growth Rate in Chronic Hepatitis B Treatment Oral Drugs Business (2019-2024)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Chronic Hepatitis B Oral Drugs Market Research Report 2024
Global Chronic Hepatitis C Treatment Oral Medicine Market Research Report 2024
Global Chronic Hepatitis C Treatment Drugs Market Research Report 2024
Hepatitis B Virus Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Adult Chronic Hepatitis B Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti HBV Drugs Market Research Report 2025
Global Oral Anti HBV Drugs Market Research Report 2024
Global Oral Antiviral Medicine Market Research Report 2025
Global Hepatitis B Diagnostic Tests Market Research Report 2024
Anti Hepatitis Virus Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chronic Hepatitis B Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatitis B Treatment Market Insights Forecast to 2030
Hepatitis B Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hepatic Antiviral Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Antiviral Medicines for COVID 19 Market Research Report 2024
Global Oral Azvudine Tablets Market Research Report 2024
Global Hepatitis B Human Immunoglobulin Market Research Report 2024
Hepatitis B Therapeutic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chronic Liver Diseases Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liver Cancer Treatment Drug Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions